He served as a member of the scientific committee at the METACancer consortium, aimed at investigating biomarkers for breast cancer.
Pôsobil ako člen vedeckej riadiacej komisie v konzorciu METAcancer, zameranom na hľadanie biomarkerov rakoviny prsníka.